436 related articles for article (PubMed ID: 16314541)
1. Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death.
Rodondi N; Newman AB; Vittinghoff E; de Rekeneire N; Satterfield S; Harris TB; Bauer DC
Arch Intern Med; 2005 Nov; 165(21):2460-6. PubMed ID: 16314541
[TBL] [Abstract][Full Text] [Related]
2. Subclinical hypothyroidism and the risk of coronary heart disease and mortality.
Rodondi N; den Elzen WP; Bauer DC; Cappola AR; Razvi S; Walsh JP; Asvold BO; Iervasi G; Imaizumi M; Collet TH; Bremner A; Maisonneuve P; Sgarbi JA; Khaw KT; Vanderpump MP; Newman AB; Cornuz J; Franklyn JA; Westendorp RG; Vittinghoff E; Gussekloo J;
JAMA; 2010 Sep; 304(12):1365-74. PubMed ID: 20858880
[TBL] [Abstract][Full Text] [Related]
3. Subclinical hypothyroidism is associated with a low-grade inflammation, increased triglyceride levels and predicts cardiovascular disease in males below 50 years.
Kvetny J; Heldgaard PE; Bladbjerg EM; Gram J
Clin Endocrinol (Oxf); 2004 Aug; 61(2):232-8. PubMed ID: 15272919
[TBL] [Abstract][Full Text] [Related]
4. The association of fasting glucose levels with congestive heart failure in diabetic adults > or =65 years: the Cardiovascular Health Study.
Barzilay JI; Kronmal RA; Gottdiener JS; Smith NL; Burke GL; Tracy R; Savage PJ; Carlson M
J Am Coll Cardiol; 2004 Jun; 43(12):2236-41. PubMed ID: 15193686
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular risk factors in middle-aged women with subclinical hypothyroidism.
Luboshitzky R; Herer P
Neuro Endocrinol Lett; 2004 Aug; 25(4):262-6. PubMed ID: 15361814
[TBL] [Abstract][Full Text] [Related]
6. [Possible consequences of subclinical hypothyroidism].
Weissel M
Acta Med Austriaca; 2003; 30(4):93-7. PubMed ID: 14710477
[TBL] [Abstract][Full Text] [Related]
7. [Prolactin levels before and after stimulation with thyroliberin in primary hypothyroidism].
Trejbal D; Petrásová D; Macejová A; Lazúrová I; Wágnerová H; Trejbalová L
Vnitr Lek; 2002 Feb; 48(2):96-9. PubMed ID: 11949229
[TBL] [Abstract][Full Text] [Related]
8. [Subclinical thyroid disease--should we treat, should we screen for it?].
Trbojević B
Srp Arh Celok Lek; 2003; 131(11-12):467-73. PubMed ID: 15114790
[TBL] [Abstract][Full Text] [Related]
9. Neonatal congenital hypothyroidism screening in Addis Ababa, Ethiopia.
Feleke Y; Enquoselassie F; Deneke F; Abdulkadir J; Hawariat GW; Tilahun M; Mekbib T
East Afr Med J; 2000 Jul; 77(7):377-81. PubMed ID: 12862157
[TBL] [Abstract][Full Text] [Related]
10. Effects of catecholamine-beta-adrenoceptor-cAMP system on severe patients with heart failure.
Peng Y; Shan J; Qi X; Xue H; Rong C; Yao D; Guo Z; Zheng S
Chin Med J (Engl); 2003 Oct; 116(10):1459-63. PubMed ID: 14570600
[TBL] [Abstract][Full Text] [Related]
11. Spectrum of subclinical and overt hypothyroidism: effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues.
Staub JJ; Althaus BU; Engler H; Ryff AS; Trabucco P; Marquardt K; Burckhardt D; Girard J; Weintraub BD
Am J Med; 1992 Jun; 92(6):631-42. PubMed ID: 1605145
[TBL] [Abstract][Full Text] [Related]
12. Thyroid Dysfunction in Heart Failure and Cardiovascular Outcomes.
Kannan L; Shaw PA; Morley MP; Brandimarto J; Fang JC; Sweitzer NK; Cappola TP; Cappola AR
Circ Heart Fail; 2018 Dec; 11(12):e005266. PubMed ID: 30562095
[TBL] [Abstract][Full Text] [Related]
13. TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study).
Meier C; Staub JJ; Roth CB; Guglielmetti M; Kunz M; Miserez AR; Drewe J; Huber P; Herzog R; Müller B
J Clin Endocrinol Metab; 2001 Oct; 86(10):4860-6. PubMed ID: 11600554
[TBL] [Abstract][Full Text] [Related]
14. Subclinical thyroid dysfunction and fracture risk: a meta-analysis.
Blum MR; Bauer DC; Collet TH; Fink HA; Cappola AR; da Costa BR; Wirth CD; Peeters RP; Åsvold BO; den Elzen WP; Luben RN; Imaizumi M; Bremner AP; Gogakos A; Eastell R; Kearney PM; Strotmeyer ES; Wallace ER; Hoff M; Ceresini G; Rivadeneira F; Uitterlinden AG; Stott DJ; Westendorp RG; Khaw KT; Langhammer A; Ferrucci L; Gussekloo J; Williams GR; Walsh JP; Jüni P; Aujesky D; Rodondi N;
JAMA; 2015 May; 313(20):2055-65. PubMed ID: 26010634
[TBL] [Abstract][Full Text] [Related]
15. ["Subclinical" thyroid disease].
Jorde R
Tidsskr Nor Laegeforen; 2002 Apr; 122(9):938-40. PubMed ID: 12082841
[TBL] [Abstract][Full Text] [Related]
16. Factors influencing clinical decisions to initiate thyroxine therapy for patients with mildly increased serum thyrotropin (5.1-10.0 mIU/L).
Fatourechi V; Lankarani M; Schryver PG; Vanness DJ; Long KH; Klee GG
Mayo Clin Proc; 2003 May; 78(5):554-60. PubMed ID: 12744541
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and relevance of thyroid dysfunction in 1922 cholesterol screening participants.
Pirich C; Müllner M; Sinzinger H
J Clin Epidemiol; 2000 Jun; 53(6):623-9. PubMed ID: 10880781
[TBL] [Abstract][Full Text] [Related]
18. [Subclinical functional disorders of the thyroid gland].
Corssmit EP; Wiersinga WM
Ned Tijdschr Geneeskd; 2003 Jun; 147(24):1162-7. PubMed ID: 12845835
[TBL] [Abstract][Full Text] [Related]
19. Risk of congestive heart failure in an elderly population treated with peripheral alpha-1 antagonists.
Bryson CL; Smith NL; Kuller LH; Chaves PH; Manolio TA; Lewis W; Boyko EJ; Furberg CD; Psaty BM
J Am Geriatr Soc; 2004 Oct; 52(10):1648-54. PubMed ID: 15450040
[TBL] [Abstract][Full Text] [Related]
20. Changes in thyroid function and evolution of subclinical thyroid disease in older men.
Tan SY; Chubb SAP; Flicker L; Almeida OP; Golledge J; Hankey GJ; Yeap BB
Clin Endocrinol (Oxf); 2024 Feb; 100(2):170-180. PubMed ID: 38059618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
